share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer JOHNSON RADY A

辉瑞 | 4:持股变动声明-高管 JOHNSON RADY A
美股SEC公告 ·  08/16 15:24

Moomoo AI 已提取核心信息

Rady A Johnson, Executive Vice President of Pfizer Inc (PFE), has been reported to engage in a transaction involving the company's stock on August 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Investors are advised to await further disclosures for more comprehensive information regarding the transaction's impact on their investment decisions.
Rady A Johnson, Executive Vice President of Pfizer Inc (PFE), has been reported to engage in a transaction involving the company's stock on August 15, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of shares, were not disclosed in the announcement. The action type and status of the transaction were also not provided. Investors are advised to await further disclosures for more comprehensive information regarding the transaction's impact on their investment decisions.
据报道,辉瑞公司(PFE)的执行副总裁Rady A Johnson在2024年8月15日进行了一笔涉及公司股票的交易。交易具体细节,包括股数、股份性质、交易价格以及股票总价值,未在公告中披露。交易的类型和状态也未提供。建议投资者等待进一步披露,以获取关于交易对其投资决策影响的更全面信息。
据报道,辉瑞公司(PFE)的执行副总裁Rady A Johnson在2024年8月15日进行了一笔涉及公司股票的交易。交易具体细节,包括股数、股份性质、交易价格以及股票总价值,未在公告中披露。交易的类型和状态也未提供。建议投资者等待进一步披露,以获取关于交易对其投资决策影响的更全面信息。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息